Cargando…

Clinical outcomes of temocillin use for invasive Enterobacterales infections: a single-centre retrospective analysis

BACKGROUND: With increasing frequency of resistant Gram-negative bacteria, temocillin has potential utility in reducing carbapenem use. The 2020 EUCAST guideline changes temocillin breakpoints and reclassifies isolates with an MIC of 0.001–16 mg/L as ‘susceptible, increased exposure’ necessitating 6...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heard, Katie L, Killington, Kieran, Mughal, Nabeela, Moore, Luke S P, Hughes, Stephen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210019/ https://www.ncbi.nlm.nih.gov/pubmed/34223083 http://dx.doi.org/10.1093/jacamr/dlab005

Ejemplares similares

Optimization of antimicrobial dosing in patients with acute kidney injury: a single-centre observational study
por: Hughes, Stephen, et al.
Publicado: (2022)

Clinical and microbiological evaluation of temocillin for bloodstream infections with Enterobacterales: a Belgian single-centre retrospective study
por: Oosterbos, Julie, et al.
Publicado: (2022)

Rapid detection of temocillin resistance in Enterobacterales
por: Findlay, Jacqueline, et al.
Publicado: (2023)

Impact of revised breakpoints on the categorization of susceptibility of Enterobacterales to temocillin
por: Farfour, Eric, et al.
Publicado: (2023)

Once-daily tigecycline for outpatient parenteral antibiotic therapy: a single-centre observational study
por: Hughes, Stephen, et al.
Publicado: (2019)

In vitro activity of mecillinam, temocillin and nitroxoline against MDR Enterobacterales
por: Plambeck, Lars, et al.
Publicado: (2022)

COVID-19 and fungal superinfection
por: Heard, Katie L, et al.
Publicado: (2020)

Evaluation of a thrice weekly administration of teicoplanin in the outpatient setting: a retrospective observational multicentre study
por: Asumang, John, et al.
Publicado: (2021)

Evaluating the impact of the ICNET® clinical decision support system for antimicrobial stewardship
por: Heard, Katie L., et al.
Publicado: (2019)

Activity of temocillin against ESBL-, AmpC-, and/or KPC-producing Enterobacterales isolated in Poland
por: Kuch, Alicja, et al.
Publicado: (2020)

Investigating the association between ethnicity and health outcomes in SARS-CoV-2 in a London secondary care population
por: Patel, Aatish, et al.
Publicado: (2020)

Haematological and hepatic adverse effects of ceftriaxone in ambulatory care: a dual-centre retrospective observational analysis of standard vs high dose
por: Mistry, Rakhee, et al.
Publicado: (2022)

Real-life temocillin use in Greater Paris area, effectiveness and risk factors for failure in infections caused by ESBL-producing Enterobacterales: a multicentre retrospective study
por: Dinh, Aurélien, et al.
Publicado: (2022)

Correction to: Real-life temocillin use in Greater Paris area, effectiveness and risk factors for failure in infections caused by ESBL-producing Enterobacterales: a multicentre retrospective study
Publicado: (2023)

Procalcitonin to Guide Antibacterial Prescribing in Patients Hospitalised with COVID-19
por: Hughes, Stephen, et al.
Publicado: (2021)

Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): protocol for a randomised, pragmatic trial
por: Marín-Candón, Alicia, et al.
Publicado: (2021)

Empirical use of temocillin in hospitalized patients: results from a retrospective audit
por: Kandil, Hala, et al.
Publicado: (2023)

Treating infections caused by carbapenemase-producing Enterobacterales (CPE): a pragmatic approach to antimicrobial stewardship on behalf of the UKCPA Pharmacy Infection Network (PIN)
por: Hughes, Stephen, et al.
Publicado: (2020)

Bacteraemia variation during the COVID-19 pandemic; a multi-centre UK secondary care ecological analysis
por: Denny, Sarah, et al.
Publicado: (2021)

Correction to: Empirical use of temocillin in hospitalized patients: results from a retrospective audit
Publicado: (2023)

Continuous versus intermittent infusion of temocillin in intensive care unit patients
por: Claeysoone, K, et al.
Publicado: (2005)

Temocillin: Applications in Antimicrobial Stewardship as a Potential Carbapenem-Sparing Antibiotic
por: Lupia, Tommaso, et al.
Publicado: (2022)

Clinical Efficacy of Temocillin Standard Dosing in Patients Treated with Outpatient Antimicrobial Therapy
por: Van den Broucke, Evelyne, et al.
Publicado: (2022)

A retrospective multicenter analysis of candidaemia among COVID-19 patients during the first UK pandemic wave
por: Denny, Sarah, et al.
Publicado: (2021)

Susceptibility of Escherichia coli from Community-Acquired Urinary Tract Infection to Fosfomycin, Nitrofurantoin, and Temocillin in Korea
por: Seo, Mi-Ran, et al.
Publicado: (2014)

Amoxicillin plus temocillin as an alternative empiric therapy for the treatment of severe hospital-acquired pneumonia: results from a retrospective audit
por: Habayeb, H., et al.
Publicado: (2015)

Activity of temocillin and 15 other agents, including fosfomycin and colistin, against Enterobacteriaceae in Hong Kong
por: Ip, Margaret, et al.
Publicado: (2017)

Cost-Effectiveness Analysis of Temocillin Treatment in Patients with Febrile UTI Accounting for the Emergence of Antibiotic Resistance
por: Larsson, Sofie, et al.
Publicado: (2022)

Budget impact analysis of temocillin insurance coverage for urinary tract infections caused by ESBL-producing pathogens in Iran
por: Seyedifar, Meysam, et al.
Publicado: (2023)

Prognostic Modeling of COVID-19 Using Artificial Intelligence in the United Kingdom: Model Development and Validation
por: Abdulaal, Ahmed, et al.
Publicado: (2020)

WHY STOP? A prospective observational vignette-based study to determine the cognitive-behavioural effects of rapid diagnostic PCR-based point-of-care test results on antibiotic cessation in ICU infections
por: Singh, Suveer, et al.
Publicado: (2023)

Evaluating the long-term impact of an antimicrobial stewardship programme in a Central London mixed medical and surgical intensive care unit
por: Singh, Shivani, et al.
Publicado: (2022)

Population Pharmacokinetics of Temocillin Administered by Continuous Infusion in Patients with Septic Shock Associated with Intra-Abdominal Infection and Ascitic Fluid Effusion
por: Ngougni Pokem, Perrin, et al.
Publicado: (2022)

Temocillin use as a carbapenem-sparing option in a UK teaching hospital for treating serious Gram-negative bacterial infections
por: Enoch, D A, et al.
Publicado: (2022)

Clinical utility and cost-effectiveness of bacterial 16S rRNA and targeted PCR based diagnostic testing in a UK microbiology laboratory network
por: Aggarwal, Dinesh, et al.
Publicado: (2020)

Comparison of deep learning with regression analysis in creating predictive models for SARS-CoV-2 outcomes
por: Abdulaal, Ahmed, et al.
Publicado: (2020)

Impact of ceftriaxone and temocillin on fecal abundance of extended-spectrum β-lactamase producing Escherichia coli in a mouse model
por: Chenouard, Rachel, et al.
Publicado: (2021)

Optimising the initial investigation of suspected cases of SARS-CoV-2 reinfection
por: Pallett, Scott JC., et al.
Publicado: (2021)

Novel inhaled antifungal for pseudomembranous Aspergillus tracheobronchitis complicating connective tissue disease
por: Singh, Shivani, et al.
Publicado: (2023)

Mechanisms of intrinsic resistance and acquired susceptibility of Pseudomonas aeruginosa isolated from cystic fibrosis patients to temocillin, a revived antibiotic
por: Chalhoub, Hussein, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o6k3beuk6dad6t6l687uoi5a32